{"id":170525,"date":"2014-12-31T09:58:51","date_gmt":"2014-12-31T14:58:51","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/albert-einstein-college-of-medicine-announces-new-chair-of-department-of-microbiology-immunology.php"},"modified":"2014-12-31T09:58:51","modified_gmt":"2014-12-31T14:58:51","slug":"albert-einstein-college-of-medicine-announces-new-chair-of-department-of-microbiology-immunology","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/albert-einstein-college-of-medicine-announces-new-chair-of-department-of-microbiology-immunology.php","title":{"rendered":"Albert Einstein College of Medicine Announces New Chair of Department of Microbiology &amp; Immunology"},"content":{"rendered":"<p><p>Contact Information         <\/p>\n<p>      Available for logged-in reporters only    <\/p>\n<p>    Newswise  December 30, 2014(BRONX, NY)Albert Einstein    College of Medicine of Yeshiva University today named    Steven A. Porcelli, M.D., the new chair of    the department of microbiology &    immunology. A noted immunologist, Dr. Porcelli is currently    the Murray and Evelyne Weinstock Chair in Microbiology &    Immunology and professor of medicine at Einstein.  <\/p>\n<p>    Dr. Porcelli graduated summa cum laude from Columbia    University, received his M.D. from Yale University and    completed a medical residency at Temple University Hospital. He    served as fellow and then junior faculty member in the division    of rheumatology, immunology and allergy at Brigham and Womens    Hospital in Boston.  <\/p>\n<p>    Steve Porcelli is an outstanding physician-scientist who has    made major contributions to our understanding of how the immune    system responds to tuberculosis infection. He has been an    excellent mentor to junior faculty within the department of    microbiology & immunology and a terrific colleague who is    eminently qualified to assume the responsibilities of chairing    this superb department, said Allen M. Spiegel, M.D., the    Marilyn and Stanley M. Katz Dean at Einstein.  <\/p>\n<p>    While an assistant professor at Harvard Medical School in the    1990s, Dr. Porcelli discovered the CD1-dependent pathway for    antigen presentation to the immune systems T cells. His work    revealed that T cellsthought to recognize only protein    antigenscan recognize lipid antigens as well. Those studies    aroused Dr. Porcellis interest in tuberculosis, caused by a    bacterium (Myocobacterium tuberculosis) that is about one-third    lipid by weight. He has been studying various aspects of TB    ever since.  <\/p>\n<p>    Dr. Porcelli was recruited to Einstein as the Irene Diamond    Associate Professor in Immunology in 1999. Since 2004 he has    served as scientific director of Einsteins Flow Cytometry Core    facility and of FACS (fluorescence-activated cell sorting)    resources for the Einstein-Montefiore Center for AIDS Research.  <\/p>\n<p>    As part of his TB research, Dr. Porcelli is working to develop    a more effective TB vaccine in collaboration with Einstein    scientists William R. Jacobs, Jr., Ph.D., and John Chan, M.D. (Dr. Jacobs is professor of    microbiology & immunology and of genetics and a Howard    Hughes Medical Institute investigator; Dr. Chan is professor of    medicine and of microbiology & immunology and attending    physician in infectious disease, department of medicine, at    Montefiore    Medical Center, the University Hospital for Einstein.) That    research has led to a new live attenuated vaccine, built from    M. tuberculosis and created by deleting two genes that    contribute to the bacteriums virulence. Mouse studies    involving this double mutant vaccine showed that a single    immunization was significantly more effective than the BCG    vaccinethe only current TB vaccine, now nearly a century    oldand also extremely safe.  <\/p>\n<p>    Another aspect of Dr. Porcells TB research involves a    subpopulation of lipid-recognizing T cells called invariant    Natural Killer T (iNKT) cells, which respond to M. tuberculosis    infections. A naturally occurring class of molecules called    glycolipids can selectively activate iNKT cellsand synthetic    glycolipids called alpha-galactosylceramides activate them even    more strongly. In research funded by the National Institute of    Allergy and Infectious Diseases, Dr. Porcelli is synthesizing    different alpha-galactosylceramide molecules and testing    whether they can improve the immune response against M.    tuberculosis, possibly as adjuvantssubstances that increase    the bodys response to vaccines.  <\/p>\n<p>    Since receiving his first major independent research project    grant in 1996, Dr. Porcelli has been continuously funded as a    principal investigator by the National Institutes of Health.    His TB research is supported by four major NIH grants with    current annual funding totaling approximately $1.36 million.    Dr. Porcelli is also supported by a $113,000 grant from the    Bill & Melinda Gates Foundation to help develop vaccines to    prevent HIV infection.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the original post: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.newswise.com\/articles\/view\/627894\/?sc=rsmn\/RK=0\/RS=Zfxyzd9noJdWFak3JWxxFTu3t5Q-\" title=\"Albert Einstein College of Medicine Announces New Chair of Department of Microbiology &amp; Immunology\">Albert Einstein College of Medicine Announces New Chair of Department of Microbiology &amp; Immunology<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Contact Information Available for logged-in reporters only Newswise December 30, 2014(BRONX, NY)Albert Einstein College of Medicine of Yeshiva University today named Steven A. Porcelli, M.D., the new chair of the department of microbiology &#038; immunology. A noted immunologist, Dr <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/albert-einstein-college-of-medicine-announces-new-chair-of-department-of-microbiology-immunology.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-170525","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/170525"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=170525"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/170525\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=170525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=170525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=170525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}